Kenji Hashimoto

2.6k total citations
54 papers, 1.1k citations indexed

About

Kenji Hashimoto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kenji Hashimoto has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Kenji Hashimoto's work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Treatment and Pharmacology (5 papers) and Glioma Diagnosis and Treatment (4 papers). Kenji Hashimoto is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Cancer Treatment and Pharmacology (5 papers) and Glioma Diagnosis and Treatment (4 papers). Kenji Hashimoto collaborates with scholars based in Japan, United States and United Kingdom. Kenji Hashimoto's co-authors include Yasuhiro Fujiwara, Kan Yonemori, Kenji Tamura, Chikako Shimizu, Haruo Ohtani, Takashi Nakayama, Fuminori Katou, Yoshiko Watanabe, Osamu Yoshie and Masashi Ando and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kenji Hashimoto

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Hashimoto Japan 19 568 289 248 175 140 54 1.1k
Vito Longo Italy 23 372 0.7× 467 1.6× 130 0.5× 168 1.0× 149 1.1× 38 1.1k
Matthew R. Eber United States 16 614 1.1× 354 1.2× 200 0.8× 180 1.0× 108 0.8× 29 1.1k
Marleen Renard Belgium 21 333 0.6× 347 1.2× 234 0.9× 90 0.5× 138 1.0× 50 1.5k
Anthony J. Jaslowski United States 14 898 1.6× 255 0.9× 192 0.8× 103 0.6× 71 0.5× 31 1.2k
Małgorzata Wągrowska‐Danilewicz Poland 19 229 0.4× 267 0.9× 153 0.6× 298 1.7× 225 1.6× 146 1.3k
Shinji Itoyama Japan 20 478 0.8× 353 1.2× 192 0.8× 88 0.5× 236 1.7× 64 1.3k
Roeliene C. Kruizinga Netherlands 13 555 1.0× 253 0.9× 111 0.4× 322 1.8× 92 0.7× 14 1.1k
Monika Hermansson United Kingdom 15 206 0.4× 437 1.5× 152 0.6× 253 1.4× 135 1.0× 19 1.6k
Senem Karabulut Türkiye 18 483 0.9× 310 1.1× 243 1.0× 142 0.8× 121 0.9× 96 1.0k
Yuiko Sato Japan 23 364 0.6× 649 2.2× 98 0.4× 162 0.9× 114 0.8× 59 1.4k

Countries citing papers authored by Kenji Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Kenji Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Hashimoto more than expected).

Fields of papers citing papers by Kenji Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Hashimoto. The network helps show where Kenji Hashimoto may publish in the future.

Co-authorship network of co-authors of Kenji Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Hashimoto. A scholar is included among the top collaborators of Kenji Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Hashimoto. Kenji Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Fengjie, Yajuan Fan, Yue Cui, et al.. (2025). SSRI-induced modulation of cytokines, barrier permeability, and BDNF in adolescent depression. BMC Psychiatry. 26(1). 16–16.
2.
Tanabe, Yuko, Seiji Shiraishi, Kenji Hashimoto, et al.. (2020). Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients. BMC Cancer. 20(1). 325–325. 13 indexed citations
3.
Pal, Sumanta K., David F. McDermott, Michael B. Atkins, et al.. (2020). Patient‐reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma. British Journal of Urology. 126(1). 73–82. 21 indexed citations
4.
Hashimoto, Kenji, Hitoshi Tsuda, Fumiaki Koizumi, et al.. (2014). Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer. Annals of Oncology. 25(10). 1973–1979. 51 indexed citations
5.
Hashimoto, Kenji, Noriyuki Katsumata, Akihiro Hirakawa, et al.. (2014). Can Oncologists Predict Survival for Patients with Progressive Disease After Standard Chemotherapies?. Current Oncology. 21(2). 84–90. 18 indexed citations
6.
Sato, Yasuharu, Nobuya Ohara, Kenji Hashimoto, et al.. (2014). Systemic IgG4-related disease with extensive peripheral nerve involvement that progressed from localized IgG4-related lymphadenopathy: an autopsy case. Diagnostic Pathology. 9(1). 41–41. 18 indexed citations
7.
Hashimoto, Kenji, Chikako Shimizu, Hitoshi Tsuda, et al.. (2012). Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome. Oncology. 82(3). 168–174. 17 indexed citations
8.
Shoji, Hirokazu, Kenji Hashimoto, Makoto Kodaira, et al.. (2012). Hematologic Safety of Breast Cancer Chemotherapies in Patients with Hepatitis B or C Virus Infection. Oncology. 82(4). 228–233. 5 indexed citations
9.
Kojima, Yuki, Kenji Hashimoto, Masashi Ando, et al.. (2012). Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis. Cancer Chemotherapy and Pharmacology. 70(3). 391–397. 15 indexed citations
10.
Hashimoto, Kenji, Yuko Sasajima, Masashi Ando, et al.. (2012). Immunohistochemical Profile for Unknown Primary Adenocarcinoma. PLoS ONE. 7(1). e31181–e31181. 17 indexed citations
11.
Shimizu, Chikako, Kenji Hashimoto, Takayuki Kinoshita, et al.. (2011). Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer. Breast Cancer. 20(2). 145–151. 16 indexed citations
12.
Shintaku, Masayuki & Kenji Hashimoto. (2011). Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult. Brain Tumor Pathology. 29(1). 31–36. 7 indexed citations
13.
Hashimoto, Kenji, Kan Yonemori, Chikako Shimizu, et al.. (2010). A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer. Medical Oncology. 28(2). 434–440. 3 indexed citations
14.
Hashimoto, Kenji & Kenji Tamura. (2010). [Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer].. PubMed. 37(7). 1187–91. 4 indexed citations
15.
Katou, Fuminori, Haruo Ohtani, Yoshiko Watanabe, et al.. (2007). Differing Phenotypes between Intraepithelial and Stromal Lymphocytes in Early-Stage Tongue Cancer. Cancer Research. 67(23). 11195–11201. 43 indexed citations
16.
Hashimoto, Kenji, et al.. (1990). [Long-term follow-up studies of bronchial asthma in children. I. Prognosis and risk factors].. PubMed. 39(7). 621–30. 1 indexed citations
17.
Hashimoto, Kenji, et al.. (1990). [Long-term follow up studies of bronchial asthma in children. II. Prognosis and complications, treatment and allergic evaluations].. PubMed. 39(8). 662–9. 3 indexed citations
18.
Fukushima, Yoshihisa, et al.. (1986). [A 14q+ marker chromosome due to t(11;14) in a case of nonsecretory plasma cell leukemia].. PubMed. 27(11). 2124–30. 2 indexed citations
19.
Hashimoto, Kenji, et al.. (1973). Collagenase activity in rheumatoid nodules. Ultrastructural in vivo studies. Acta Dermato Venereologica. 53(6). 439–448. 4 indexed citations
20.
Hashimoto, Kenji, et al.. (1963). Kinetics of the Hydrogenation of Benzene on a Nickel Catalyst supported on Kieselguhr. Chemical engineering. 27(8). 558–566. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vito Longo Breakdown of academic impact, for papers by Matthew R. Eber Breakdown of academic impact, for papers by Marleen Renard Breakdown of academic impact, for papers by Anthony J. Jaslowski Breakdown of academic impact, for papers by Małgorzata Wągrowska‐Danilewicz Breakdown of academic impact, for papers by Shinji Itoyama Breakdown of academic impact, for papers by Roeliene C. Kruizinga Breakdown of academic impact, for papers by Monika Hermansson Breakdown of academic impact, for papers by Senem Karabulut Breakdown of academic impact, for papers by Yuiko Sato
Rankless by CCL
2026